$4.3MSeed, 2 April 2026
Funds development of its AI precision oncology platform for ovarian, breast and pancreatic cancers.
- Amount
- $4.3M
- Stage
- Seed
- Announced
- 2 April 2026
- Lead
- TK & Partners
- Other investors
- Mesa Verde Venture Partners, National Foundation for Cancer Research, Asian Fund for Cancer Research
- Use of funds
- Funds development of its AI precision oncology platform for ovarian, breast and pancreatic cancers.
- Checked
- Announced by the company
- Sources
- Acurion closes $4.3M seed round for AI oncology diagnostics vcaonline.com
Acurion closes $4.3M seed round for AI oncology diagnostics alleywatch.com